RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis

Inactivation of the RB1 tumor suppressor gene is common in several types of therapy-resistant cancers, including metastatic castration-resistant prostate cancer, and predicts poor clinical outcomes. Effective therapeutic strategies against RB1-deficient cancers remain elusive. Here, we showed that R...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mu-En, Chen, Jiaqi, Lu, Yi, Bawcom, Alyssa R., Wu, Jinjin, Ou, Jianhong, Asara, John M., Armstrong, Andrew J., Wang, Qianben, Li, Lei, Wang, Yuzhuo, Huang, Jiaoti, Chen, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178842/
https://www.ncbi.nlm.nih.gov/pubmed/36928314
http://dx.doi.org/10.1172/JCI166647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178842/
https://www.ncbi.nlm.nih.gov/pubmed/36928314
http://dx.doi.org/10.1172/JCI166647

Ejemplares similares